Compare ARK Genomic Revolution ETF (ARKG) vs EHang Holdings Ltd - ADR (EH) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs EHang Holdings Ltd - ADR — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while EHang Holdings Ltd - ADR trades at $5.59 (market cap $423.98M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, EHang Holdings Ltd - ADR nearer its low. Which is the better fit depends on your goals.
| ARKG | EH | |
|---|---|---|
Sector | Sector/Thematic | Industrials |
52-Week High | $43.57 | $19.99 |
52-Week Low | $23.09 | $5.52 |
Market Cap | — | $423.98M |
Enterprise Value | — | $363.64M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
EHang Holdings (EH) trades at $5.59, down 3.45% today, with a bearish technical signal from moving averages. The company reported Q1 2026 revenue of $418M, flat year-over-year but sharply lower sequentially due to delivery timing. Despite a high gross margin of 61.53%, net losses persist with a -77.56% margin. Cash flow improved in 2024 but reversed negative in 2025. Recent news highlights volatility, including an 18% surge on June 15, 2026, followed by concerns over Q1 sales missing forecasts.
The outlook remains speculative with significant execution risks amid ongoing losses, though analyst consensus suggests moderate upside to a $6.97 target. Investment opportunity hinges on commercial scaling of eVTOL operations, but high cash burn and competitive pressures pose substantial risks. Sentiment is divided, with 40% sell ratings reflecting skepticism over near-term profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About EHang Holdings Ltd - ADR
EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
Read more on EH →
